Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.60 | 2.60 |
| PEG Ratio (TTM) | -1.17 | 1.13 |
| P/S Ratio (TTM) | 0.54 | 1.40 |
| P/B Ratio (TTM) | -3.18 | 2.20 |
| P/FCF Ratio (TTM) | 8.35 | 18.10 |
| Price to 5YR AVG Earnings Ratio | -164.32 | -86.22 |
| Price to 5YR AVG FCF Ratio | 11.85 | 17.02 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.31% | 1.16% |
| ROE (TTM) | -27.12% | 17.31% |
| Net Profit Margin (TTM) | 4.69% | 1.69% |
| ROIC 5YR AVG | 12.21% | 18.68% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1,024.45% | -53.94% | -46.60% |
| Revenue | 2.43% | 2.02% | 3.92% |
| Net Income | 987.27% | -56.56% | -48.81% |
| Cash Flow | 369.99% | -12.21% | 18.38% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.64 | 1.21 |
| Quick Ratio (TTM) | 0.47 | 1.17 |
| D/E Ratio (TTM) | -2.80 | 1.00 |
| Interest Coverage (TTM) | 2.07 | 4.83 |
| Piotroski F-Score | 9 | 6 |
| Altman Z-Score | 2.66 | 2.16 |
| LTL to 5YR AVG FCF | 10.98 | 5.42 |
| Shares Outstanding Growth 5YR AVG | -3.09% | 2.87% |